An interventional study of Computerized Cognitive Training and Active tDCS (tDCS) on DLPFC in Mild Cognitive Impairment, Primary Progressive Aphasia and Dementia, sponsored by Johns Hopkins University. Terminated at 1 site in United States. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Cognitive Dysfunction by Johns Hopkins University — 13 open to participants now, 15 under way, 1 of them phase 3. Cognitive Dysfunction · Johns Hopkins University.
Among the 34 studies in Cognitive Dysfunction by Johns Hopkins University, this one is the 30th largest by enrollment of the 33 interventional ones that give a count, is one of 7 that started in 2023, is one of 22 with no phase, and was the 24th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →13 of the 34 studies in Cognitive Dysfunction by Johns Hopkins University are open now, in 1 country. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 65+ · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 60–100 · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 65+ · Healthy volunteers
Johns Hopkins University · Sites in United States
Ages 60+
Johns Hopkins University · Sites in United States
Ages 18–100
By country, each count listing its studies:
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 50 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 5 is below the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 52 across the 33 interventional studies, 350 across the 1 observational. Of the 17 that completed or were terminated, 10 (59%) have results posted.
This tab as a report to print or save as PDF → With an account.
Johns Hopkins University is the lead sponsor of 1,817 studies on the registry; 316 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
7 of the studies in Cognitive Dysfunction by Johns Hopkins University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05611918Johns Hopkins UniversityREpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study | 2026-12-31 |
| NCT07454824Johns Hopkins Universitye-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most | 2027-02-06 |
| NCT04123314Johns Hopkins UniversityPsilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease | 2027-06-30 |
| NCT06351540Johns Hopkins UniversityExamining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance | 2027-07-01 |
| NCT04765137Johns Hopkins UniversityEvaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI) | 2027-07-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 34 studies in Cognitive Dysfunction by Johns Hopkins University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary objective of this research is to evaluate the effects of non-invasive brain stimulation and computerized cognitive training on executive functioning in individuals with Primary Progressive Aphasia (PPA), mild cognitive impairment (MCI), or dementia. In this study, investigators will use transcranial direct current stimulation (tDCS) to stimulate the left dorsolateral prefrontal cortex (DLPFC). Previous studies have demonstrated that tDCS over the DLPFC led to improvements in attention deficit caused by stroke, Parkinson's Disease, and major depression as well as language deficits caused by neurodegenerative conditions such as primary progressive aphasia or mild cognitive impairment. The investigators seek to expand on this literature by investigating how anodal tDCS paired with and without cognitive training will impact executive functioning in PPA with Frontotemporal Dementia or Alzheimer's Disease pathology and Mild Cognitive Impairment/Alzheimer's Disease (e.g. shifting, updating, monitoring, and manipulation).
In this within-subject cross-over protocol, all participants will receive both, cognitive training and brain stimulation tDCS. Participants will be randomly assigned to begin with either cognitive training and brain stimulation (dual therapy) or just brain stimulation (monotherapy) and will receive the complementary therapy program in the second round of treatment. During each period of therapy, participants will receive 50 treatment sessions over the course of approximately 10 weeks. The computerized cognitive training and brain stimulation will both be preprogrammed to be done at home by the participant.
Inclusion Criteria:
Exclusion Criteria:
Exclusion Criteria for MRI participation:
Participants will receive active tDCS on DLPFC + Cognitive Intervention(s) first and then receive only active tDCS Intervention after a three-month washout period.
Other: Computerized Cognitive Training · Device: Active tDCS (tDCS) on DLPFC
Participants will receive active tDCS on the DLPFC-only intervention first and then receive active tDCS + Cognitive Intervention(s) after a three-month washout period.
Device: Active tDCS (tDCS) on DLPFC
Computerized Cognitive training (BrainHQ or Constant Therapy)
Device: Active tDCS on DLPFC Stimulation will be delivered by a constant current stimulator (Mind STIM). The electrical current will be administered to a pre-specified region of the brain (DLPFC). The stimulation will be delivered at an intensity of 2 milliamperes (mA) (estimated current density 0.04 mA/cm2; estimated total charge 0.048 Coulombs/cm2) in a ramp-like fashion for a maximum of 20 minutes.
Change in Language Composite Outcome
A single language composite outcome will be generated by computing the mean of the percentage accuracy of the following naming, spelling, and sentence comprehension and repetition tasks: Boston Naming Test, Hopkins Action Naming Assessment, National Alzheimer's Coordinating Center Sentence Repetition. The investigators will calculate the percentage accuracy for each task and average them in order to get a composite score.
Time frame: Up to 6 weeks before intervention (before Phase 1) up to 1 week post-intervention (after Phase 1). Phase 1 intervention lasted 10 weeks.
Change in Executive Composite Outcome
A single executive composite will be generated by computing the mean of the percentage accuracy of the tasks below reflecting new learning and memory, processing speed and executive functioning, attention and working memory, and verbal fluency respectively: Rey Auditory Verbal Learning Test, Digit Span, Category Fluency, and Verbal Fluency. The investigators will calculate the percentage accuracy for each task and average them in order to get a composite score.
Time frame: Up to 6 weeks before intervention (before Phase 1) up to 1 week post-intervention (after Phase 1). Phase 1 intervention lasted 10 weeks.
Change in Global Cognitive Scores
This will be measured using the Montreal Cognitive Assessment (MoCA). Score range 0-30 points, higher is better.
Time frame: Up to 6 weeks before intervention (before Phase 1) up to 1 week post-intervention (after Phase 1). Phase 1 intervention lasted 10 weeks.
Change in Working Memory Capacity.
This will be measured using Digit Span Backward for verbal working memory. The digit span backward is a well-established task that assesses rote immediate verbal memory and working memory. Participants are presented with a series of digits and are instructed to repeat the digits in the reverse order. Scoring is based on the number of digits shown in a trial (i.e. 1,7 is 2 digits). There are two trials for each span, and if both trials are correct, the score is a whole number (i.e. 2). If one trial is incorrect in a span, subtract 0.5 from that tier (i.e. 1.5). Increase in score from before to after intervention is considered a benefit. The range of the score is from 0 to 8, with 0 being the lowest/worst score and 8 being the highest/best score possible.
Time frame: Up to 6 weeks before intervention (before Phase 1) up to 1 week post-intervention (after Phase 1). Phase 1 intervention lasted 10 weeks.
| Milestone | Active tDCS on the DLPFC + Cognitive Intervention, First | Active tDCS on the DLPFC-only, First |
|---|---|---|
| Started | 5 | 0 |
| Completed | 5 | 0 |
| Not completed | 0 | 0 |
| Milestone | Active tDCS on the DLPFC + Cognitive Intervention, First | Active tDCS on the DLPFC-only, First |
|---|---|---|
| Started | 5 | 0 |
| Completed | 3 | 0 |
| Not completed | 2 | 0 |
| Withdrew: Lost to follow-up | 2 | 0 |
| Milestone | Active tDCS on the DLPFC + Cognitive Intervention, First | Active tDCS on the DLPFC-only, First |
|---|---|---|
| Started | 3 | 0 |
| Completed | 0 | 0 |
| Not completed | 3 | 0 |
| Withdrew: Withdrawal by subject | 3 | 0 |
A single language composite outcome will be generated by computing the mean of the percentage accuracy of the following naming, spelling, and sentence comprehension and repetition tasks: Boston Naming Test, Hopkins Action Naming Assessment, National Alzheimer's Coordinating Center Sentence Repetition. The investigators will calculate the percentage accuracy for each task and average them in order to get a composite score.
| Percentage accuracy | Active tDCS on the DLPFC + Cognitive Intervention(s) |
|---|---|
| Change in Language Composite Outcome | -0.54 ± 11.39 |
A single executive composite will be generated by computing the mean of the percentage accuracy of the tasks below reflecting new learning and memory, processing speed and executive functioning, attention and working memory, and verbal fluency respectively: Rey Auditory Verbal Learning Test, Digit Span, Category Fluency, and Verbal Fluency. The investigators will calculate the percentage accuracy for each task and average them in order to get a composite score.
| Percentage accuracy | Active tDCS on the DLPFC + Cognitive Intervention(s) |
|---|---|
| Change in Executive Composite Outcome | -2.33 ± 5.02 |
This will be measured using the Montreal Cognitive Assessment (MoCA). Score range 0-30 points, higher is better.
| score on a scale | Active tDCS on the DLPFC + Cognitive Intervention(s) |
|---|---|
| Change in Global Cognitive Scores | -1.33 ± 4.16 |
This will be measured using Digit Span Backward for verbal working memory. The digit span backward is a well-established task that assesses rote immediate verbal memory and working memory. Participants are presented with a series of digits and are instructed to repeat the digits in the reverse order. Scoring is based on the number of digits shown in a trial (i.e. 1,7 is 2 digits). There are two trials for each span, and if both trials are correct, the score is a whole number (i.e. 2). If one trial is incorrect in a span, subtract 0.5 from that tier (i.e. 1.5). Increase in score from before to after intervention is considered a benefit. The range of the score is from 0 to 8, with 0 being the lowest/worst score and 8 being the highest/best score possible.
| score on a scale | Active tDCS on the DLPFC + Cognitive Intervention(s) |
|---|---|
| Change in Working Memory Capacity. | 0 ± 0.61 |
Collected over From enrollment until end of follow-up, up to 5 months post end of intervention of phase 1, up to 40 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Active tDCS on the DLPFC + Cognitive Intervention(s) | 0/5 (0%) | 0/5 (0%) | 0/5 (0%) |
| Active tDCS on the DLPFC Only | — | — | — |
| Age, Continuous(Years) | All Participants |
|---|---|
| Mean | 64.2 ± 1.79 |
| Sex: Female, Male(Participants) | All Participants |
|---|---|
| Female | 3 |
| Male | 2 |
| Ethnicity (NIH/OMB)(Participants) | All Participants |
|---|---|
| Hispanic or Latino | 0 |
| Not Hispanic or Latino | 5 |
| Unknown or Not Reported | 0 |
| Race (NIH/OMB)(Participants) | All Participants |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 0 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 0 |
| White | 5 |
| More than one race | 0 |
| Unknown or Not Reported | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Aug 2023 to primary completion in Sep 2025, 25 months.
Results were first posted in Oct 2026, 1 year 1 month after primary completion.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.